<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36729115</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill</ISOAbbreviation></Journal><ArticleTitle>Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2300049</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2023.28.5.2300049</ELocationID><Abstract><AbstractText>On 21 November 2022, a wild poliovirus type 3 (WPV3) was isolated from an environmental surveillance sample of poliovirus essential facilities in the Netherlands. All 51 employees with access to this strain were screened for ongoing or recent poliovirus infection. One employee shedding WPV3 was identified on 8 December and placed in isolation; monitoring and contact tracing were initiated. WPV3 shedding continued for 4 weeks and stopped 5â€¯January 2023. Isolation was lifted 11 January and no further transmission was detected.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duizer</LastName><ForeName>Erwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruijs</LastName><ForeName>Wilhelmina Lm</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putri Hintaran</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Public Health Service Region Utrecht, Zeist, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafkamp</LastName><ForeName>Mariska C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Veer</LastName><ForeName>Margreet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Authority for Containment, Health and Youth Care Inspectorate (IGJ), Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Wierik</LastName><ForeName>Margreet Jm</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016358" MajorTopicYN="N">Contact Tracing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Global Action Plan (GAP)</Keyword><Keyword MajorTopicYN="N">Saukett strain G</Keyword><Keyword MajorTopicYN="N">containment</Keyword><Keyword MajorTopicYN="N">environmental surveillance</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">poliovirus essential facility (PEF)</Keyword><Keyword MajorTopicYN="N">wild poliovirus type 3 (WPV3)</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36729115</ArticleId><ArticleId IdType="pmc">PMC9896605</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.5.2300049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Accidentele blootstelling polio, Bijlage bij LCI-draaiboek polio. [Accidental polio exposure. Annex to LCI polio roadmap, Version: December 2020]. Bilthoven: RIVM; 2020. Available from: https://lci.rivm.nl/sites/default/files/2020-12/Bijlage%20Accidentele%20blootstelling%20polio.pdf
</Citation></Reference><Reference><Citation>World Health Organization (WHO). Public Health Management of Facility Related Exposure to Live Polioviruses. Guidance in managing exposed persons for countries hosting facilities that maintain live polioviruses. Geneva: WHO; 2019. Available from: https://polioeradication.org/wp-content/uploads/2016/07/Public-Health-Management-of-a-facility-PV-exposure.pdf
</Citation></Reference><Reference><Citation>Duizer E, Ruijs WL, van der Weijden CP, Timen A. Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill. 2017;22(21):30542. 10.2807/1560-7917.ES.2017.22.21.30542</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.21.30542</ArticleId><ArticleId IdType="pmc">PMC5479986</ArticleId><ArticleId IdType="pubmed">28597830</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). WHO Global Action Plan for Poliovirus Containment. GAPIV. Geneva: WHO; 2022. Available from: https://polioeradication.org/wp-content/uploads/2022/07/WHO-Global-Action-Plan-for-Poliovirus-Containment-GAPIV.pdf
</Citation></Reference><Reference><Citation>World Health Organization (WHO). WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use, GAPIII. Geneva: WHO; 2014. Available from: https://polioeradication.org/wp-content/uploads/2016/12/GAPIII_2014.pdf
</Citation></Reference><Reference><Citation>World Health Organization (WHO). Polio laboratory manual, 4th ed. Geneva: WHO; 2004. Available from: https://apps.who.int/iris/handle/10665/68762
</Citation></Reference><Reference><Citation>Cardemil CV, Rathee M, Gary H, Wannemuehler K, Anand A, Mach O, et al. Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000-2010. Epidemiol Infect. 2014;142(1):163-71. 10.1017/S0950268813000800</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268813000800</ArticleId><ArticleId IdType="pmc">PMC6546098</ArticleId><ArticleId IdType="pubmed">23594458</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. S1. Supplement to the WHO Polio Laboratory Manual; An alternative test algorithm for poliovirus isolation and characterization. Geneva: WHO; 2017. Available from: https://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>